Understanding what works: How some countries are beating back the coronavirus
With Europe and the United States locked in deadly battle with the coronavirus that causes…
Author: STAT
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Two manufacturers of a decades-old malaria drug that some research has suggested may be useful…
Listen: Trump’s coronavirus pivot, life inside the ICU, drug development in a pandemic
Why did the U.S. change its tune on coronavirus? What’s it like to be an…
A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half
WASHINGTON — A company that makes a medication increasingly touted as a promising coronavirus treatment,…
With the coronavirus surging, Trump wants drug development to move far faster. It can’t
For about 20 minutes on Thursday, President Trump undermined six decades of dogma on the…
STAT Plus: Preventing other Shkreli-like debacles may not save the government much money
After Martin Shkreli took a 5,000% price hike on a decades-old medicine and thwarted rivals,…
STAT Plus: ‘Organ-on-a-chip’ maker Emulate names new CEO, announces new funding
A Boston startup known for its plastic chips that simulate human organs announced the appointment…
An updated guide to the coronavirus drugs and vaccines in development
In the months since the novel coronavirus rose from a regional crisis to a global…
Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?
In the 1995 movie “Outbreak,” doctors whip up a serum from monkey blood in just…
STAT Plus: Biotech in the time of the coronavirus: Disruptions continue, but there’s some good news, too
Back again with another semi-regular column on the Covid-19 pandemic. You can read my first…
STAT Plus: Pharmalittle: WHO to launch expansive coronavirus clinical trial; FDA halts some domestic inspections
Rise and shine, everyone, another intense day is on the way. The world seems to…
Opinion: Telehealth overpromises during the Covid-19 pandemic
“No more germy waiting rooms.” That’s the pitch from telehealth companies as we face the…
Opinion: Insulin prices and pharmacy benefit manager rebates: pin the tail on the patient
Over the past 15 years, insulin prices have more than doubled. Pharmaceutical companies have been…
Opinion: Telemedicine could blunt the cost of unnecessary ED visits for Covid-19
Conversations that dominated the health policy discourse only a few weeks ago have been suspended…
Coronavirus survives on surfaces up to 72 hours. Here’s how to protect yourself
Viruses didn’t become ubiquitous by being wimps: From the rhinoviruses that cause the common cold…
STAT Plus: How to rebrand a clinical trial? For one study, Instagram influencers and a dash of wit go a long way
For the better part of four years, Samantha Meltzer-Brody has been trying to recruit thousands…
FDA postpones some inspections of U.S. manufacturing facilities
The spread of the novel coronavirus has prompted the Food and Drug Administration to temporarily…
WHO to launch multinational trial to jumpstart search for coronavirus drugs
The World Health Organization said Wednesday that it would launch a multi-arm, multi-country clinical trial…
New analysis of coronavirus risk confirms young adults are not invincible
As the Covid-19 pandemic takes an ever-larger toll across the world, researchers are expanding their…
‘It’s been kind of rough’: At the epicenter of the pandemic, a Seattle ICU nurse treats two patients at a time
Stephanie Bandyk is on the front lines of the Covid-19 pandemic: A registered nurse who…
U.S. official says data show severe coronavirus infections among millennials, not just older Americans
A top health official on the White House’s coronavirus task force warned Wednesday that young…
.jpg)
Chilean lawmakers support compulsory licensing for coronavirus medicines and vaccines
Concerned about access to treatments for the fast-spreading coronavirus, Chile’s lower house of Congress passed…
Facing medical supply shortages, Trump invokes wartime law that could give government authority over private manufacturing
WASHINGTON — President Trump on Wednesday said he would invoke the Defense Production Act, a…
Anticipating ‘shelter-in-place’ orders across the country, trade groups push for exceptions for biopharma employees
As more regional governments consider ordering residents to largely stay inside their homes to try…
Opinion: The economic rationale for strong action now against Covid-19
As governments and communities struggle to figure out the best way to deal with the…
Coronavirus will have a ‘big impact’ on one-third of U.S. clinical trial sites, survey finds
Nearly one-third of clinical trial sites expect the novel coronavirus will have a “big or…
Opinion: We know enough now to act decisively against Covid-19. Social distancing is a good place to start
In a recent and controversial First Opinion, epidemiologist and statistician John Ioannidis argues that we…
STAT Plus: Pharmalittle: Blood samples are lacking for coronavirus treatments; Europe counters Trump offer to vaccine maker
Good morning, everyone, and welcome to the middle of the week. You made it this…
Frustrated and afraid about protective gear shortages, health workers are scouring for masks on their own
Health care workers across the country tell STAT they are grappling with new hospital restrictions…
STAT Plus: Sage has a backup plan for its depression drug: Three new studies aiming for 2022 approval
After meeting with the Food and Drug Administration, Sage Therapeutics said Wednesday that it will…
Opinion: Saving lives should be good business. Why doesn’t that apply to finding new antibiotics?
I have spent my career as a biomedical entrepreneur working to develop products that have…
Revealing the hidden beauty of research: MIT’s 2020 images award winners
Sometimes the most beautiful images are ones that can’t be seen with the naked eye….
The White House is pinning its hopes on health tech to save the day. Can it deliver?
Over the past week, President Trump and his administration have made statements and taken other…
STAT Plus: Despite coronavirus disruption, major microbiome companies are cautiously optimistic about upcoming data
This was supposed to be the microbiome’s breakthrough year — and pandemic or not, it…
.jpg)
Surge in patients overwhelms telehealth services amid coronavirus pandemic
Telehealth services are sagging under the weight of an unprecedented surge in patients as hospitals…
Hospital in Boston will be converted into Covid-19 treatment center
A Texas-based health care system announced Tuesday that it would convert one of its hospitals…
Opinion: Allocate ventilators, other Covid-19 resources based on evidence, not political hunches
The emergence of Covid-19 and its worldwide spread has some of the United States’ top…
Trump lifts restrictions on telehealth services for seniors in hopes of limiting coronavirus spread
WASHINGTON — The Trump administration on Tuesday announced an unprecedented expansion of telehealth services for…
Changes in language on Facebook posts could signal need for hospitalization or emergency services
Can Facebook posts predict who might soon end up in the emergency department? They can,…
Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs
At the stroke of midnight on Tuesday morning, seven counties in the San Francisco Bay…
STAT Plus: Biotech in the time of the coronavirus: A semi-regular column on the outbreak’s impact on drug makers
This is the first in a series of semi-regular columns on the Covid-19 pandemic. In…
Opinion: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data
The current coronavirus disease, Covid-19, has been called a once-in-a-century pandemic. But it may also…
STAT Plus: Pharmalittle: FDA gives states an OK to authorize coronavirus tests; more companies race to combat Covid-19
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Merck drug reduces cough frequency but taste alterations could cloud prospects
An experimental pill from Merck significantly reduced the frequency of chronic coughing compared to a…
Regeneron says potential Covid-19 drugs could start human tests by early summer
The biotechnology firm Regeneron said it has now developed hundreds of potential medicines that could…
STAT Plus: Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow
Global spending on prescription medicines is forecast to increase between 2% and 5% annually over…
STAT Plus: As the market craters, Keros Therapeutics files for an IPO
Keros Therapeutics is filing for an IPO, according to plans made public Monday — a…
Opinion: Generic ‘identity’ gets lost when companies juggle both generic and brand drugs
We think we know generic drug companies. They challenge patents held by brand firms. They…
Opinion: Covid-19 will worsen the opioid overdose crisis if we don’t prepare now
In cities across the country, morning is peak time at almost any opioid treatment program….
Explaining a mass quarantine: What does it mean to ‘shelter in place’? And who has the power to call for it?
WASHINGTON — Six counties in the San Francisco metro area made headlines when they announced…